Latest Content

Reflections After Nine Years as a Bladder Cancer Survivor

July 3rd 2025, 1:00pm

By Chester Freeman

Article

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.

Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer

July 2nd 2025, 9:11pm

By Spencer Feldman

Article

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

This Wasn’t the Plan: My Mother and Her Silence

July 2nd 2025, 9:00pm

By Anushree Thakur

Article

In part 4, the author reflects on her mother’s silent strength and unwavering love during her cancer journey, as she cared for her daughter while silently battling her own illness.

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

July 2nd 2025, 7:00pm

By Spencer Feldman

Article

Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.

Tipping My Hat to the Heroes of the Cancer Community

July 2nd 2025, 6:00pm

By Tamron Little

Article

Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!

FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma

July 2nd 2025, 4:32pm

By Spencer Feldman

Article

The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.

Living After Cancer: A Cancer Thriver Shares Her Story

July 2nd 2025, 4:00pm

By Ryan Scott

Article

Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.

Temferon Linked to Long-Term Survival in Some With Glioblastoma

July 2nd 2025, 3:00pm

By Spencer Feldman

Article

Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized after initial progression.

A Cancer Survivor Calls Beating the Disease a ‘World Championship’

July 2nd 2025, 1:00pm

By Daniel Jernazian

Video

Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.

This Wasn’t the Plan: I Lost My Hair, Not My Fire

July 1st 2025, 9:00pm

By Anushree Thakur

Article

In part 3 of “This Wasn’t the Plan,” a young woman reflects on her father’s strength during his illness and how, after her own diagnosis, their bond became her greatest source of courage.

Social and Economic Barriers May Affect Outcomes in Blood Cancers

July 1st 2025, 8:00pm

By Alisha Kimble

Video

Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.

Survival, Symptoms and Support in Waldenström Macroglobulinemia

July 1st 2025, 7:00pm

By Spencer Feldman

Article

Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect quality of life over time.

Therapies Which Received FDA Approval in June: What You Should Know

July 1st 2025, 6:00pm

By Ryan Scott

Article

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.

A Cocktail and the Freedom I Never Expected With Cancer

July 1st 2025, 5:00pm

By Linda Cohen

Article

After years off medication, I finally enjoyed a grapefruit cocktail — symbolizing freedom from cancer’s constant shadow and hope for the future.

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

July 1st 2025, 4:00pm

By Spencer Feldman

Article

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.